CR6351A - Composiciones estimulantes del crecimiento mejoradas - Google Patents

Composiciones estimulantes del crecimiento mejoradas

Info

Publication number
CR6351A
CR6351A CR6351A CR6351A CR6351A CR 6351 A CR6351 A CR 6351A CR 6351 A CR6351 A CR 6351A CR 6351 A CR6351 A CR 6351A CR 6351 A CR6351 A CR 6351A
Authority
CR
Costa Rica
Prior art keywords
growth stimulating
improved growth
improved
stimulating compositions
formulation
Prior art date
Application number
CR6351A
Other languages
English (en)
Spanish (es)
Inventor
S Robins Daniel
Chung Shiu
J Kennedy Thomas
James Knight Peter
Jese Shao Zezhi
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CR6351A publication Critical patent/CR6351A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CR6351A 1998-11-04 2001-04-20 Composiciones estimulantes del crecimiento mejoradas CR6351A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
CR6351A true CR6351A (es) 2003-11-20

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6351A CR6351A (es) 1998-11-04 2001-04-20 Composiciones estimulantes del crecimiento mejoradas

Country Status (11)

Country Link
AR (1) AR025133A1 (fr)
AU (1) AU777393B2 (fr)
BR (2) BRPI9914996B8 (fr)
CA (1) CA2348841C (fr)
CO (1) CO5140100A1 (fr)
CR (1) CR6351A (fr)
MY (1) MY134868A (fr)
PE (1) PE20001092A1 (fr)
TW (1) TWI250027B (fr)
WO (1) WO2000025743A2 (fr)
ZA (1) ZA200103494B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4001288A1 (fr) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé de préparation d'acétate de trenbolone présentant une distribution granulométrique définie et un habitus cristallin à plaques irrégulières hexagonales
ES2948624T3 (es) 2020-11-19 2023-09-14 Fis Fabbrica Italiana Sintetici Spa Proceso mejorado para la preparación de trembolona y/o acetato de trembolona
EP4000688A1 (fr) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé pour la préparation d'acétate trenbolone ayant une distribution granulométrique définie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
BR9914996A (pt) 2001-07-10
CA2348841C (fr) 2007-04-17
AR025133A1 (es) 2002-11-13
BRPI9914996B1 (pt) 2011-11-01
MY134868A (en) 2007-12-31
PE20001092A1 (es) 2000-10-31
AU777393B2 (en) 2004-10-14
BRPI9914996B8 (pt) 2021-07-06
AU3096700A (en) 2000-05-22
WO2000025743A3 (fr) 2000-08-24
CO5140100A1 (es) 2002-03-22
WO2000025743A2 (fr) 2000-05-11
CA2348841A1 (fr) 2000-05-11
ZA200103494B (en) 2002-07-30
BRPI9914996A (pt) 2001-07-10
TWI250027B (en) 2006-03-01

Similar Documents

Publication Publication Date Title
NI200500087A (es) Derivados 4-tetrazolyl-4 fenilpiperidina para el tratamiento del dolor
Schindl et al. Diabetic neuropathic foot ulcer: successful treatment by low-intensity laser therapy
ES2344505T3 (es) Formulaciones antiparasitarias.
AR045142A1 (es) Composicion veterinaria masticable ductil de buen sabor
AR058359A1 (es) Combinaciones
BRPI0412211A (pt) composições de liberação controlada
AR026986A1 (es) Implante farmaceutico con contenido de componentes de liberacion inmediata y liberacion sostenida y metodos de administracion
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
AR098251A2 (es) Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
DK0862416T3 (da) Ikke-polymert indgivelsessystem med forhalet frigørelse
NZ336511A (en) Treating prostatic diseases using delayed and/or sustained release formulations of activated vitamin D
AR040722A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
AR044234A2 (es) Uso de una composicion que comprende oocistos de eimeria vivos
SV2008002466A (es) Oblea que contiene hormonas esteroides ref. p-sv-79.953/gh
AR044236A2 (es) Uso de una composicion que comprende esporozoitos de eimeria vivos
CR6351A (es) Composiciones estimulantes del crecimiento mejoradas
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
AR019579A1 (es) USO DE UN INICIADOR DE LA RESPUESTA SEXUAL DEL SISTEMA NERVIOSO CENTRAL PARA LA FABRICACIoN DE UNA COMPOSICIoN FARMACÉUTICA PARA LA NORMALIZACIoN DE LA CRONOMETRACIoN DE LA RESPUESTA SEXUAL O PARA LA PROFILAXIS O REDUCCIoN DE LA LESIoN TISULAR GENITAL EN MAMíFEROS
MX9205508A (es) Formulacion inyectable de liberacion prolongada y metodo para su preparacion.
AR039895A1 (es) Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla
ECSP993205A (es) Composiciones estimulantes del crecimiento mejoradas (caso aho948)
Gómez-Fernández et al. The effect of immunocastration and surgically castration on growth performance and carcass quality in fattening period of Iberian female pigs.
AR037543A1 (es) Metodo para la terapia del cancer y composicion farmaceutica
Patrizi et al. Generalized reaction to subcutaneous heparin.
TH48412A3 (th) องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง

Legal Events

Date Code Title Description
FC90 Application suspended